Abbott Cardiovascular

New data presented at #TCT2026 from the STS/ACC TVT Registry show favorable #TriClip #TEER outcomes across centers regardless of procedural volume, reinforcing its reproducibility in real-world practice.

📄 Read more: abbo.tt/4Amh0VT

Important Safety Info: abbo.tt/TriClip_ISI

#BuiltOnProof

Thank you to everyone who joined us at #TCT2026!

From clinical research to hands-on training, we explored new insights across coronary and peripheral interventions to help advance #Cardiovascular care.

📩 Keep the momentum going with post-show updates: bit.ly/4kC01dg

#CardioEd

🇯🇵Our #VoltPFA System is now approved in Japan.

Featuring an innovative balloon-in-basket design, our Volt™ PFA System is designed to deliver targeted energy while supporting efficient pulmonary vein isolation.¹

Learn more: bit.ly/4hZy8dt

U.S. Safety Info: bit.ly/3RhXedm

#RevoltAgainstTheOrdinary

References: 1. Tilz, R.R. (2025, January 17) Acute results demonstrate safety and effectiveness of balloon-based pulsed field ablation system for de novo PVI in PAF and PersAF [Late Breaking Presentation]. AF Symposium 2025, Boston MA, USA.

What an incredible TCT! From hands-on OCT Training Pavilions and a packed Ultreon 3.0 symposium featuring diverse clinical cases and expert insights, to engaging discussions with physicians at the booth, we showcased the power of imaging-guided PCI across every corner of the meeting. Our centerpiece artwork became a standout attraction and conversation starter, adding even more energy to an event filled with learning, collaboration, and innovation. Together, these moments reinforced our commitment to expanding access to life-changing technologies around the world. #TCT #OCT #Ultreon

U.S. Safety Info: bit.ly/3PA6Grv

#OCTimaging #PCI

Choose an index valve that performs now … and later.

Real-world data from over 6,000 patients show how Navitor TAVI sustains hemodynamics through 1 year.

Navitor is the index valve: abbo.tt/4iUcF5h

Important Safety Info: abbo.tt/NavitorISI